AKCEA THERAPEUTICS, INC. (36) | Business Operations (2)
- Strategic Advisory Services Agreement, by and between Registrant and B. Lynne Parshall dated, January 9, 2020 (Filed With SEC on May 6, 2020)
- Amendment No. 1 to the Strategic Collaboration, Option and License Agreement between the Registrant and Novartis Pharma AG dated February 22, 2019 (Filed With SEC on May 9, 2019)